Robert Ang - Nov 1, 2024 Form 4 Insider Report for Vor Biopharma Inc. (VOR)

Role
PRESIDENT AND CEO, Director
Signature
/s/ Katie Kazem, Attorney-in-Fact
Stock symbol
VOR
Transactions as of
Nov 1, 2024
Transactions value $
-$2,201
Form type
4
Date filed
11/5/2024, 04:15 PM
Previous filing
Sep 4, 2024
Next filing
Nov 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VOR Common Stock Tax liability -$2.2K -2.75K -0.35% $0.80 790K Nov 1, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units.